Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,201,200
$182.49 P/Share
|
|
Apr 29
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 29
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,820,000
$182.49 P/Share
|
|
Apr 28
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Apr 28
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,638,000
$182.32 P/Share
|
|
Apr 28
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$910,000
$182.32 P/Share
|
|
Apr 28
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 27
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,174,800
$178.29 P/Share
|
|
Apr 27
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-31.12%
|
$870,000
$174.65 P/Share
|
|
Apr 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 26
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$855,000
$171.77 P/Share
|
|
Apr 26
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 26
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$855,000
$171.77 P/Share
|
|
Apr 26
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
Apr 23
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-2.95%
|
$1,899,912
$172.52 P/Share
|
|
Apr 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.13%
|
$2,580,000
$172.51 P/Share
|
|
Apr 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
|
Apr 22
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,108,800
$168.26 P/Share
|
|
Apr 22
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 22
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,680,000
$168.26 P/Share
|
|
Apr 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Apr 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,422,000
$158.6 P/Share
|
|
Apr 21
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$790,000
$158.6 P/Share
|
|
Apr 21
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 20
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,056,000
$160.32 P/Share
|
|
Apr 20
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-48.25%
|
$815,000
$163.94 P/Share
|
|
Apr 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 19
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$830,000
$166.17 P/Share
|
|
Apr 19
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 16
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.27%
|
$1,822,590
$165.34 P/Share
|
|
Apr 15
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,042,800
$158.76 P/Share
|
|
Apr 15
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 15
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,580,000
$158.76 P/Share
|
|
Apr 14
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$765,000
$153.75 P/Share
|
|
Apr 14
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 14
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Apr 14
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,377,000
$153.75 P/Share
|
|
Apr 13
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$963,600
$146.62 P/Share
|
|
Apr 13
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
|
Apr 13
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.92%
|
$2,190,000
$146.62 P/Share
|
|
Apr 13
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
|
Apr 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$710,000
$142.46 P/Share
|
|
Apr 12
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
Apr 12
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$710,000
$142.46 P/Share
|
|
Apr 12
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 12
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-57.16%
|
$695,000
$139.95 P/Share
|
|
Apr 12
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Apr 09
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.88%
|
$1,535,394
$139.2 P/Share
|